Tofacitinib: The Next Step in Treating Rheumatoid Arthritis

Speciality: Rheumatology


Speaker:

Dr. Nikhil Gupta | Ex Fellow Rheumatology - CMC Vellore, Ex Senior Research Fellow Rheumatology - AIIMS, Delhi Senior Consultant Rheumatologist, Saroj Hospital & Sant Parmanand Hospital

Description:

A warm welcome to all the medical professionals in this interesting session on the role of tofacitinib in managing rheumatoid arthritis. 

Immunological pathways play a crucial role in disease management, especially in the case of rheumatological disease. Managing rheumatoid arthritis often becomes difficult due to its rate of progression and associated health issues. 

The webinar will help in gaining important insights on JAK-inhibiting drugs like tofacitinib in controlling rheumatoid arthritis. It is a competitive inhibitor of JAK that binds to adenosine triphosphate in the kinase domain.

Tofacitinib inhibits the process of intracellular signaling from the receptor to the cellular nucleus and inhibits the inflammation process via inhibition of the Janus kinases, which eventually help in controlling rheumatoid arthritis. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

2.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

3.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

4.

The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

5.

Virtual Reality Travel Reduces Cancer Pain.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot